Trial intelligence / Profile preview

HSK21542 for postoperative analgesia in laparoscopic surgery

NCT04738357Phase 3Completed

Sponsor
Haisco Pharmaceutical Group Co., Ltd.
Start
Mar 2021
Primary completion
Jul 2021
Modality
Peptides, Small Molecules
Countries
1
01

Overview

A Phase 3 trial of hsk21542 in postoperative pain, sponsored by Haisco Pharmaceutical Group Co., Ltd.. Started Mar 2021; status: completed.

02

Drugs

hsk21542
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT04738357.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04738357.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call